Citation Impact
Citing Papers
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
2005
TOR Signaling in Growth and Metabolism
2006 Standout
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Treatment of kidney cancer
2009 StandoutNobel
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
Thyroid cancer
2016 Standout
The Tuberous Sclerosis Complex
2006 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Targeting mammalian target of rapamycin (mTOR) for health and diseases
2006
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Current development of mTOR inhibitors as anticancer agents
2006
Hepatocellular carcinoma
2012 Standout
Combination of a rapamycin analog (CCI‐779) and interferon‐γ is more effective than single agents in treating a mouse model of tuberous sclerosis complex
2006
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
The Akt-mTOR tango and its relevance to cancer
2005
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
2006 Nature
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Progress in molecular-based management of differentiated thyroid cancer
2013
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Tuberous sclerosis
2008 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
2015
Application and interpretation of current autophagy inhibitors and activators
2013
An expanding role for mTOR in cancer
2005
Targeting autophagy in cancer
2017 Standout
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
2006
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
2011 Standout
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
2006
The PI3K Pathway in Human Disease
2017 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Dynamics and diversity in autophagy mechanisms: lessons from yeast
2009 StandoutNobel
Termination of autophagy and reformation of lysosomes regulated by mTOR
2010 StandoutNature
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Genomics and Signaling Pathways in Hepatocellular Carcinoma
2007
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
2008 Standout
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
2009
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors
2006
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort
2015
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Metastasis as an evolutionary process
2016 Science
Fibronectin Stimulates Non–Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways
2006
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL
2005
Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth
2014 StandoutNobel
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma
2016
Works of Stéphane Vignot being referenced
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles
2015
La signalisation FGF/FGFR : implication dans l’oncogenèse et perspectives thérapeutiques
2015
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma
2011
mTOR-targeted therapy of cancer with rapamycin derivatives
2005
Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer
2013
Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.
2003